Siah1 has been found to be upregulated in osteosarcoma, where it increases resistance to doxorubicin treatment [70]; hence, a therapy targeting the HIF transcription factor in osteosarcoma should consider the inhibition of Siah1, to prevent its accumulation. This evidence concerns the gene SIAH1 and osteosarcoma.